MEDIOS AG (ILM1.DE) Stock Price, Forecast & Analysis
Europe - Frankfurt Stock Exchange - FRA:ILM1 - DE000A1MMCC8 - Common Stock
ILM1.DE Key Statistics, Chart & Performance
The current stock price of ILM1.DE is 14.48 EUR. In the past month the price increased by 18.3%. In the past year, price increased by 9.7%.
ILM1.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| AMP.MI | AMPLIFON SPA | 26.2 | 3.14B | ||
| AXNA.DE | AMPLIFON SPA | 25.91 | 3.11B | ||
| FAGR.BR | FAGRON | 17.86 | 1.54B | ||
| UPR.I | UNIPHAR PLC | 16.66 | 951.32M | ||
| BLC.PA | BASTIDE LE CONFORT MEDICAL | 365.71 | 188.67M | ||
| PRE.MI | PREDICT SPA | 13.67 | 4.57M | ||
| VMED.DE | VIROMED MEDICAL AG | N/A | 72.90M |
Related stock screener links
About ILM1.DE
Company Profile
Medios AG is a holding company, which engages in the provision of pharmaceutical drugs. The company is headquartered in Berlin, Berlin and currently employs 1,006 full-time employees. The firm covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. The company operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.
Company Info
MEDIOS AG
Heidestrasse 9
Berlin BERLIN DE
Employees: 712
Phone: 4930232566800
MEDIOS AG / ILM1.DE FAQ
What does ILM1 do?
Medios AG is a holding company, which engages in the provision of pharmaceutical drugs. The company is headquartered in Berlin, Berlin and currently employs 1,006 full-time employees. The firm covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. The company operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.
Can you provide the latest stock price for MEDIOS AG?
The current stock price of ILM1.DE is 14.48 EUR. The price decreased by -2.43% in the last trading session.
Does MEDIOS AG pay dividends?
ILM1.DE does not pay a dividend.
What is the ChartMill rating of MEDIOS AG stock?
ILM1.DE has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Where is MEDIOS AG (ILM1.DE) stock traded?
ILM1.DE stock is listed on the Frankfurt Stock Exchange exchange.
What is the analyst forecast for ILM1.DE stock?
11 analysts have analysed ILM1.DE and the average price target is 24.07 EUR. This implies a price increase of 66.24% is expected in the next year compared to the current price of 14.48.
What is the market capitalization of ILM1 stock?
MEDIOS AG (ILM1.DE) has a market capitalization of 369.38M EUR. This makes ILM1.DE a Small Cap stock.
ILM1.DE Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to ILM1.DE. When comparing the yearly performance of all stocks, ILM1.DE turns out to be only a medium performer in the overall market: it outperformed 51.38% of all stocks.
ILM1.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to ILM1.DE. While ILM1.DE seems to be doing ok healthwise, there are quite some concerns on its profitability.
ILM1.DE Financial Highlights
Over the last trailing twelve months ILM1.DE reported a non-GAAP Earnings per Share(EPS) of 0.87. The EPS increased by 63.63% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.09% | ||
| ROA | 2.34% | ||
| ROE | 4.25% | ||
| Debt/Equity | 0.32 |
ILM1.DE Forecast & Estimates
11 analysts have analysed ILM1.DE and the average price target is 24.07 EUR. This implies a price increase of 66.24% is expected in the next year compared to the current price of 14.48.
For the next year, analysts expect an EPS growth of 6.71% and a revenue growth 7.23% for ILM1.DE